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The etiology of a medical con-
dition might seem an unlikely subject
to arouse intense feelings. Yet few medical disor-
ders have stirred up as much passion and divisiveness
among scientists and the general public as autism has
in recent years. The heat of the controversy has even
attracted attention from periodicals such as The Wall
Street Journal, the Columbia Journalism Review, and
Wired magazine—seemingly improbable forums for a
medical debate. Why all the furor?
At the eye of the storm is the startling climb
in the numbers of children who have been diag-
nosed with one of the autism spectrum disorders
(ASDs). The most severe ASD
is autistic disorder
(which often is
called simply
“autism”);
other forms include Asperger syndrome and the much
rarer childhood disintegrative disorder. In the United
States, the diagnosis of ASDs increased roughly 10-fold
over the course of a decade, from 4–5 children per
10,000 in the 1980s to 30–60 children per 10,000 in the
1990s, according to a report in the August 2003 Journal
of Autism and Developmental Disorders. The 5 May 2006
issue of Morbidity and Mortality Weekly Report describes
the results of two parent surveys from 2003 and 2004,
which suggested that 55–57 children per 10,000 had
autism (however, an editorial note points out that, due
to the nature of the surveys, parents of children with
other ASDs may have reported their children as
having autistic disorder). 
Some scientists believe that much of the
upsurge is the result of increased awareness
of ASDs or changes in diagnostic criteria,
which would suggest that the true preva-
lence of the disorders has been stable over
time. Others disagree. “It is premature to
state that there is no increase in prevalence,”
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says W. Ian Lipkin, a professor of neurolo-
gy, anatomy, and neurobiology at Colum-
bia University. “None of the studies to date
has been designed to definitively address
the issue.”
The prevalence of ASDs plays into the
fundamental question of what causes these
disorders. If the number of cases is truly on
the rise, then it would seem likely that
some change in the environment is driving
up the total. That’s partly what has divided
scientists into opposing camps—they can-
not agree on the relative importance of
genetic and environmental factors in the
disorders’ etiology. 
Alas, answering the prevalence question
might not end that debate. “Even if the
prevalence of autism were stable,” says
Lipkin, “you would not be able to rule out
the possibility of an environmental trig-
ger.” That’s because very little is known
about the mechanisms that cause autism,
be they environmental or genetic.
“The study of autism was, until recent-
ly, largely dominated by the field of psy-
chology, where characterizing the behaviors
and developing reliable instruments for
diagnosis have been major areas of research
over the past few decades,” says Irva Hertz-
Picciotto, an epidemiologist at the Univ-
ersity of California, Davis. 
Indeed, the core symptoms of ASDs—
social disinterest, repetitive and overly
focused behavior, and problems in com-
munication, usually appearing before 3
years of age—have been well described.
Much less research has focused on the caus-
es of these symptoms.
Several investigations dating back to
the 1970s indicate that identical twins
have a much higher concordance rate of
ASDs than fraternal twins, according to a
report in the Spring 1998 issue of Mental
Retardation and Developmental Disabilities
Research Reviews. Those studies provide
some of the best evidence that these disor-
ders have a strong genetic component. But
the identity of the genes involved, much
less how they produce ASDs, has not been
established. Moreover, the concordance
rate for identical twins is not 100%, which
suggests that at least some cases must be
associated with environmental or epigenet-
ic factors. 
A few cases of ASDs have been clearly
linked to environmental insults. These
include prenatal exposure to chemical
agents such as thalidomide and valproic
acid, as well as to infectious agents such as
the rubella and influenza viruses. Here
again, the concordance rate is not 100%,
which suggests that a genetic predisposi-
tion is necessary for chemical and micro-
bial factors to act as triggers.
Tantalizing clues like these are prompt-
ing scientists to reconsider the research
agenda for ASDs. Martha Herbert, a pedi-
atric neurologist at Harvard Medical
School, and her colleagues have been
applying the methods of genomics to iden-
tify environmentally responsive genes that
might be important in these disorders. 
“When you realize that the widespread
changes we’re seeing in autistic brains may
occur in parallel with or even downstream
from widespread changes in the body—
such as in the immune system—and that
these changes may be environmentally trig-
gered, you start looking for ways to think
more broadly about genetic vulnerability.
It can’t be just about ‘brain genes,’”
Herbert says.
Some new epidemiological studies also
are looking for gene–environment interac-
tions. According to Diana Schendel, an
epidemiologist and project officer for
autism research at the CDC, which funds
one of the projects, these initiatives will be
able to examine many possible causal path-
ways to ASDs, including both genetic and
environmental causes that may lead to the
development of the disorders in different
subgroups of children. 
Some of these projects are already
under way, whereas others will begin soon.
All of the scientists involved, however,
believe their research will finally provide
some of the answers that everyone has been
looking for.
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CHARGE
The Childhood Autism Risks from Gen-
etics and the Environment (CHARGE)
project is unique among the large ASD
epidemiological studies. It focuses solely
on autistic disorder, and it emphasizes a
search for environmental factors—includ-
ing a broad array of chemicals in food, con-
sumer products, and ambient air, as well as
infectious and medical exposures—that
might be linked to the disorder. The study
is funded by the NIH.
CHARGE is a case–control study in
which a group of autistic children aged 2 to
5 years is compared to a group of age-
matched controls in a population-based
study. “Because of the California Depart-
ment of Developmental Services’ system of
Regional Centers [nonprofit corporations
that coordinate health care services and
support for citizens with developmental
disabilities], we have a handle on enumer-
ating a high proportion of the children
newly diagnosed with autism in our
defined area over a specific time period,”
says Hertz-Picciotto, the principal investi-
gator of the CHARGE study. “Similarly,
we can enumerate the children in the same
area and time period who are not cases. We
then sample from both.”
The project was initiated in 2002 with
the goal of recruiting 1,000 to 2,000 chil-
dren. Half of the children will be autistic.
The other half will make up two control
groups: one group of children with devel-
opmental delays (but not an ASD) and a
second group of children selected from the
general population without regard to
developmental characteristics. 
The advantage of the case–control
design is that scientists can acquire large
numbers of children with the disorder. By
comparison, in a cohort design researchers
would need a very large sample size, given
the prevalence of autism, to acquire the
same number of cases.
Hertz-Picciotto expects to have
enrolled nearly 700 children by August
2006, the end of the first funding period.
“I’ve applied for another five-year grant,”
she says, “and I hope to be funded to enroll
nine hundred in that round, which would
bring us to sixteen hundred children.” 
The CHARGE team is looking at pos-
sible exposures during the prenatal period
and early childhood. Some of the data will
be gathered through comprehensive inter-
views with parents, but Hertz-Picciotto
admits that this is not the best way to look
for exposures. “You ask people questions,
and their answers may be colored by the
fact that they know they have a child with
a condition,” she says. “They may spend a
lot of time thinking about what they might
have done or what might have gone wrong,
and they may have preconceived ideas
about what caused [the disorder]. They
might not be as objective.” Such problems
with postdiagnosis interview information
are recognized as a weakness of retrospec-
tive studies.
The scientists are getting around this
issue by examining each child’s medical
records and those of the mother during
pregnancy and delivery—nonsubjective
data gathered in the course of routine
obstetric care. They are also collecting
blood, urine, and hair specimens that will
be analyzed in the laboratory. 
The study has already provided some
intriguing leads. “We’re finding that the
immune system seems to function at a lower
level in autism,” says Hertz-Picciotto.
“That’s an important clue. It could mean
that whatever causes autism also disrupts the
immune system, or it could be that the
immune system disrupts neural develop-
ment so that something goes awry in laying
down brain circuitry prenatally or in the
early postnatal period.” [For more informa-
tion on the CHARGE study, see p. 1119,
this issue.]
ABC
The Autism Birth Cohort (ABC) Study,
now under way in Norway, is a large
prospective design that is expected to gath-
er information on 100,000 babies. The
work is being led by scientists at the
Mailman School of Public Health at
Columbia University, who are collaborat-
ing with colleagues at the Norwegian
Institute of Public Health, with funding
from the U.S. National Institute of
Neurological Disorders and Stroke. 
“When you want to know why some
people are more at risk than others in a
population, then that’s best answered using
a cohort design,” says Ezra Susser, an epi-
demiologist at Columbia University and a
co-investigator on the ABC project.
“When we think about environmental
causes of [ASDs], we’re probably interested
in phenomena that occur prior to birth or
perhaps shortly after birth. So you want to
collect prospective data from people as
early as possible in pregnancy.” Because
ASDs are not common, the study will need
large numbers of children to have enough
statistical power, according to Susser.
So far the ABC team has recruited
75,000 pregnant Norwegian mothers, but
Susser is hoping for more. “We’ve got
enough to look for an environmental risk
factor, but you need larger numbers for
studying gene–environment interactions,
which could turn out to be important,” he
says. It’s possible the team could acquire
greater numbers by collaborating with
other studies. One candidate for collabora-
tion is the Avon Longitudinal Study of
Parents and Children in the United
Kingdom, which is looking at the complex
ways in which environmental features may
relate to optimal development and health
in children. But there’s been no agreement
yet, Susser says.
Even so, the ABC scientists are opti-
mistic about their study. “Little is known
about the natural history of [ASDs],” says
Lipkin, who is the principal investigator of
the project. “By starting prenatally, we’re
collecting detailed, critical information
about environmental exposures in an unbi-
ased fashion.”
The scientists are also collecting plas-
ma, serum, RNA, and DNA. “We have
extraordinary biological materials,” says
Lipkin. “We can pursue biomarkers as well
as exposure to toxicants and infection. We
also have maternal DNA, paternal DNA,
and the child’s DNA [so-called trio data];
thus we can look for the appearance of
novel mutations,” he adds.
The ABC researchers will follow the
children through time, with parents
answering questionnaires about the health
and social interactions of their children as
they reach 6, 18, and 36 months of age. “It
may be that the developmental trajectory
tells us much more than a single time point
can ever tell us about the pathogenesis of
[ASDs],” says Mady Hornig, a physician-
scientist at Columbia University who par-
ticipates in the project.
Despite their enthusiasm for the pro-
ject’s potential, the ABC scientists feel they
could accomplish much more if they only
had the funding. “The pity of it is we have
no money to do the biological work,” says
Lipkin. “We can collect the samples and do
the questionnaires, but we’ve been unable
to get funding to look for any of the envi-
ronmental factors. We’re collecting blood,
but we won’t know whether there’s a bio-
marker until we do a biomarker analysis.
We have funds to collect RNA, but in
order to do the transcript profiling we need
approximately four hundred dollars per
sample,” he says.
Lipkin adds that there’s only so much
that one can do with questionnaire data.
“We do ask about infection and diet, but
that’s not the same as having a lab value
that can validate what was reported, and
then look at a direct correlation with the
outcome,” he says.
Lipkin believes that part of the prob-
lem is that searching for environmental
factors goes against the current research
paradigm in ASDs. “The focus is on genet-
ic factors,” he says. “Infectious diseases,
Focus | Tracing the Origins of Autismtoxicology, and immunology receive short
shrift. The ABC is clearly the right oppor-
tunity to pursue these other leads because
we have the ideal samples to survey prena-
tally and postnatally,” he says. 
The scientists are just now receiving
the responses to the 36-month question-
naire. “It’ll probably be another two years
before we have our first report,” Hornig
says. Funds are now in place to study the
children at 36 months; however, the team
hopes to follow them for a lifetime, accord-
ing to Hornig. 
CADDRE
In response to the Children’s Health Act of
2000, the CDC established and funds six
Centers for Autism and Developmental
Disabilities Research and Epidemiology
(CADDRE) to investigate potential risk
factors for ASDs. The multisite approach
offers a study group that is geographically
and demographically more representative of
the general U.S. population than a smaller
regional study could provide, according to
Craig Newschaffer, an epidemiologist and
principal investigator at the Johns Hopkins
Bloomberg School of Public Health
CADDRE site.
According to Newschaffer, the CAD-
DRE sites will use a case cohort design in
which the exposure patterns of the ASD
cases are compared to a random sample of
children living in the same geographic area.
A third study group, consisting of neurode-
velopmentally impaired children who do not
have an ASD, will round out the sample
populations. The investigators hope to enroll
a total of 650 to 900 children, aged 3 to 5
years, in each study group across all the sites,
making CADDRE the largest study of its
kind in the United States, says Newschaffer.
A uniform protocol across the sites will allow
the scientists to pool their data. 
CADDRE will collect and archive
blood, cheek cell, and hair samples from the
children in order to investigate a broad range
of potential risk factors. “We’re not focused
on the environment as much as CHARGE
is,” says Newschaffer, “but we are collecting
data on questionnaires and reviewing med-
ical records on exposure, in addition to the
biosampling for exposures.”
The scientists should have sufficient
numbers to look at gene–environment inter-
actions. “We are collecting DNA from the
parents and the kids from each of the
groups. We’ll have trio data in each of the
three groups, a potentially powerful design,”
says Newschaffer.
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Name of Study (Location)
Autism Birth Cohort (Norway)
California Autism Twin Study
(United States)
Centers for Autism and
Developmental Disabilities
Research and Epidemiology
(United States)
Childhood Autism Risks from
Genetics and the Environment
(United States)
Early Markers for Autism
(United States)
Markers for Autism Risk in
Babies—Learning Early Signs
(United States)
Goal
Investigate prenatal and postnatal environmental
exposures that may lead to ASDs
Study the behavior and learning styles of children
with autism and their twins
Compare environmental exposure patterns of 
children with ASDs, neurodevelopmentally
impaired children without ASDs, and the 
general population
Investigate prenatal and early childhood environ-
mental exposures that may contribute to ASDs
Analyze maternal and infant blood samples for early
biomarkers of ASDs
Study prenatal factors that may affect development
of ASDs in children with at least one sibling with 
an ASD
Study Size
100,000
300 twin
pairs
2,700
2,000
400
unknown
Time Frame
2004–2008
2004–2009
2000–2011 
(to date)
2002–2006
(possible 5-year
extension)
2004–2006
2006–2011
(planned)
Ages Studied
Gestation–
3 years
Not specified
3–5 years
2–5 years
Gestation–
3 years
Gestation–
unknown 
Funding Source(s)
Columbia University,
Norwegian Insititute
of Public Health,
NINDS
NIMH
NIH
NIH
NIMH, National
Alliance for Autism
Research
unknown
Key to U.S. Funding Agencies: NIMH—National Institute of Mental Health; NINDS—National Institute of Neurological Disorders and Stroke; NIH—National Institutes of Health
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CADDRE scientists will also character-
ize the behavior of the children, as well as
describe any comorbid medical conditions
and atypical physical features. The goal is to
sort out different etiologic subgroups with-
in the autism spectrum. As Newschaffer
explains, “There are a lot of possible reasons
why we’ve had a hard time coming up with
genetic and nongenetic risk factors. One of
them is that autism is likely a heterogeneous
condition, with different etiologies produc-
ing kids with what appear to be similar phe-
notypic profiles. If you don’t separate out
the different etiologic groups, it’s going to
be very hard to find an association with a
gene or an exposure. If we limit our analy-
ses to kids that have a certain profile, we’re
going to be able to make some informed
guesses about what profiles might allow risk
factors to emerge,” he says. The CADDRE
sites will begin recruiting children into the
study in the fall of 2006.
More Studies, More Acronyms
There are several other smaller epidemio-
logical studies in the works. In California,
scientists are tapping into specimen banks
that have stored blood samples taken from
mothers during pregnancy and from their
children at birth. The Early Markers for
Autism (EMA) study employs a case–
control design, with about 100 children
with an ASD (primarily autism), 100 who
are developmentally delayed, and 200
from the general population. “We can cor-
relate what’s happening in the mom and
the baby, which is really exciting,” says
Lisa Croen, a perinatal epidemiologist at
the Kaiser Permanente Division of
Research in California and the project’s
principal investigator.
EMA is a multidisciplinary collabora-
tion with epidemiologists, geneticists,
immunologists, neurovirologists, and endo-
crinologists, according to Croen. “Because
autism is so complex, it’s important for all
these researchers to communicate with each
other. I think EMA is a model for how to
do research in autism,” she says. EMA is
unique, according to Croen, because the
study will be looking for biological markers
of ASDs very early in development, during
gestation, and at birth. “This allows us to
focus on mechanisms that may be leading
to autism rather than mechanisms that are
consequences of having autism,” she says.
The EMA scientists are investigating
genetic and nongenetic factors, with a focus
on the immune dysregulation hypothesis of
ASDs. “We’re measuring different kinds of
immune markers, including immuno-
globulin levels and antibodies to specific
infectious agents, cytokines, and autoanti-
bodies,” says Croen. “We’re looking for
things that distinguish kids who are subse-
quently diagnosed with autism from those
who aren’t. This will help us understand the
pathobiology of autism—the mechanisms
that are leading to the dysregulation in
development.”
The three-year EMA is currently in its
last year. “We still have lots of analyses to
do,” says Croen, “but we’re beginning to
write some papers. We’re finding differences
between the children in levels of certain
proteins measured in the circulating blood
collected from mothers during pregnancy. I
think the study has much to contribute to
our understanding of the biology of what
might be going wrong.”
Croen is also an investigator on the
California Autism Twin Study (CATS),
which expects to recruit 300 identical and
fraternal twin pairs born between 1987 and
1999 in which at least one of the twins has
an ASD. Comparing the twin pairs will
allow the scientists to estimate the heritabil-
ity of ASDs—the relative genetic and envi-
ronmental contributions to the disorder.
“Knowing the behavioral and developmen-
tal differences between the twins might help
us understand the effects of gene expres-
sion, the in utero environment, and envi-
ronmental triggers,” Croen says.
Hertz-Picciotto is also excited about a
five-year study that she and her colleagues
hope to begin soon. Unlike CHARGE, the
new effort, called MARBLES (Markers for
Autism Risk in Babies—Learning Early
Signs), will be a prospective study in which
data will be gathered before the children are
diagnosed. Pregnant women who already
have at least one child with autism will be
enrolled right at the beginning of pregnan-
cy. The mothers will keep diaries about
their symptoms and health-related events,
and the researchers will collect cord blood
samples and placentas. 
Based on previous research, Hertz-
Picciotto expects that about 1 in 10 siblings
of the autistic children will also have the
disorder, and perhaps 1 in 4 or 5 will be “on
spectrum” with a related but less severe con-
dition such as Asperger syndrome, or with
some symptoms of the broad behavioral
phenotype, such as language delays and
atypical social skills. “This work is comple-
mentary to the case–control approach, and
should provide us with a lot of information
that will build on what we find in
CHARGE. It should be a phenomenal
resource,” she says.
You Say You Want a Revolution
In April 2004, the U.S. DHHS issued a
publication,  Congressional Appropriations
Committee Report on the State of Autism
Research, describing recommendations
made by a panel of expert scientists con-
vened by the Interagency Autism Coord-
inating Committee (IACC). The IACC
panel suggested an ambitious agenda,
which included the goal of identifying envi-
ronmental risk factors and their associated
developmental windows within a four- to
six-year period, as well as identifying genet-
ic and nongenetic causes of ASDs and their
interactions within seven to ten years. 
Hertz-Picciotto, a member of the IACC
panel, thinks these goals should be taken
with a grain of salt. “I’m optimistic that we
will have identified some environmental
risk factors, and may have excluded a few
others, between 2008 and 2010—but by no
means will we have the final word. The
genetics and the gene–environment interac-
tions may be even tougher. Unfortunately, I
don’t see enough groups working on the
environmental contribution to autism, so it
may be slower than projected,” she says.
Mark Blaxill, vice president of
SafeMinds, a parent-led advocacy group,
also believes that environmental risk factors
don’t receive enough consideration. “The
CDC has not addressed the crisis in autism
responsibly,” he says. “They should be rais-
ing the alarm, and they have failed to do so.
They should be asking why so many chil-
dren are sick. Instead, they’ve tried to sug-
gest a degree of doubt about the increases,
and that diverts attention and funding from
environmental causes.”
Schendel responds, “It is clear that more
children than ever before are being classified
as having an ASD. It is important that we
treat common developmental disorders,
and especially the ASDs, as conditions of
urgent public health concern. The CDC’s
efforts in addressing this public health con-
cern include funding for ASD monitoring
programs to understand ASD trends, fund-
ing for research into the genetic and envi-
ronmental causes of ASDs, and education
and outreach programs to promote early
identification and timely intervention for
all children with developmental problems.”
Despite the promise of the new epi-
demiological studies, some researchers are
still dismayed, as one scientist put it, that
“geneticists are running the show, and
ignoring the environmental aspects.” What
would it take for things to change? Blaxill
invokes the ideas of philosopher Thomas
Kuhn, who suggested that scientific revolu-
tions occur when an old paradigm is
replaced by a new one. “I believe we’re in
the middle of a paradigm shift,” Blaxill says.
“The dramatic explosion of autism rates
does not fit the genetic model. It’s an anom-
aly that will kill the old paradigm.” 
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--- Other Major Environmental Health–Related Studies
Name of Study (Location)
Agricultural Health Study 
(United States)
Australian Multi-Centre Study 
of Environment and Immune
Function
Avon Longitudinal Study of
Parents and Children 
(United Kingdom)
Bangladesh Vitamin E and
Selenium Trial
Diesel Particle Exposure and 
Lung Cancer (United States)
French Longitudinal Study 
of Children
GABRIEL—A Multidisciplinary
Study to Identify the Genetic and
Environmental Causes of Asthma
in the European Community
Gene–Environment Interactions in
Facial Clefts (Denmark, Norway)
Genetic and Environmental
Influences on Childhood Growth
(Nepal)
Health Effects of Arsenic
Longitudinal Study (Bangladesh)
Longitudinal Study of Australian
Children
National Children’s Study 
(United States)
NewGeneris (European Union)
Swiss Study on Childhood Allergy
and Respiratory Symptoms with
Respect to Air Pollution, Climate,
and Pollen
Singapore Cohort Study of Diet
and Cancer/Singapore Chinese
Health Study
Sister Study (United States)
Southern Community Cohort
Study (United States)
The Environmental Determinants
of Diabetes in the Young (United
States, Finland, Germany, Sweden)
Goal
Evaluate the role of agricultural exposures in the
development of cancer and other diseases in the
farming community
Examine how environmental factors influence
immune diseases and how immune disorders vary
by latitude across Australia
Determine the current problems in child health 
and development and how they may be 
prevented
Investigate whether vitamin E and/or selenium 
has a beneficial effect in reducing skin cancers 
and other types of cancer
Assess the association between exposure to diesel
exhaust and lung cancer mortality
Describe child growth at different ages, assess 
levels of exposure to the main environmental 
pollutants, and analyze the links between 
exposure and public health
Examine the roles of genetic and environmental
factors influencing the development of asthma
Use advances in molecular technologies to provide
a new level of understanding for a complex birth
defect trait
Elucidate the roles of genetic and environmental
factors influencing childhood growth and 
development
Prospectively examine the health effects of arsenic
among a population chronically exposed to the
chemical through contaminated drinking water
Assess emerging health and developmental 
concerns and their determinants in children
Examine the effects of environmental influences 
on the health and development of children
Investigate exposure to chemicals in food and the
environment and their connection with childhood
cancer and immune disorders
Investigate the association between long-term
exposure to air pollution and respiratory health
and allergies in children
Elucidate the role of diet and its interaction with
genetic factors in the causation of human cancer
Learn how the environment and genetics affect 
the chances of getting breast cancer
Gain new information about the causes of cancer,
heart disease, and other common illnesses
Identify infectious agents, dietary factors, or other
environmental agents, including psychosocial 
factors, that trigger type 1 diabetes mellitus
Study Size
90,000
1,000
14,000
4,500
55,750
20,000
40,000
200,000
900
15,000
10,000
100,000
600,000
17,846
63,257
50,000
100,000
7,092
Time Frame
1993–2008
2003–2008
1991–2010
2005–2010
2001–2007
2005–undeter-
mined
2006–2009
1998–2007
2002–2007
2000–2011
2003–2009
2000–2006
2006–2001
1997–2008
1999–2010
2003–2013
2002–2007
2004–2023
Ages Studied
Children, adults
Teenagers,
adults 
Infant–early
adulthood
25–65 years
Adults
Birth–
adulthood
Children, adults
Infants
3–18 years
18–75 years
Infant–12 years
Gestation–
21 years
Birth–7 years
6–14 years
45–74 years
35–74 years
40–79 years
Infant–15 years
Funding Source(s)
NCI, NIEHS, EPA
National Multiple
Sclerosis Society
(U.S.)
UK Medical Research
Council, Wellcome
Trust, others
NIH
NCI
French government,
others
European
Commission
NIDCR
NICHD
NIH
Australian 
government
NICHD, NIEHS, EPA,
CDC
European Community
Swiss government
NCI, NIEHS
NIEHS
NCI
NIDDK, NIAID, NICHD,
NIEHS, CDC, JDRF
Key to U.S. Funding Agencies: CDC—Centers for Disease Control and Prevention; EPA—Environmental Protection Agency; JDRF—Juvenile Diabetes Research Foundation; NCI—National Cancer Institute; NIAID—National Institute of
Allergy and Infectious Diseases; NICHD—National Institute of Child Health and Human Development; NIDCR—National Institute of Dental and Craniofacial Research; NIDDK—National Institute of Diabetes and Digestive and Kidney
Diseases; NIEHS—National Institute of Environmental Health Sciences; NIH—National Institutes of Health
(funding discontinued
after 2007)